DAFTAR PUSTAKA
1. Speroff.L; Fritz. M.A. Female Infertility.Clinical Gynecologic Endocrinology & Infertility,Lippincott Williams and Wilkins. 7th Edition, 2005:1014-41.
2. J.B.Bruno. Angiogenic factors and ovarian follicle development. Vol 6, 371-379. 2-6-2009
3. Neulen J, Wenzel D . A perfect tool for the measurement of biologically active VEGF-A in your samples. The New reliatech vegf-a relida , 1-12. 2010
4. Asimakopoulos. Follicular Fluid Levels of Vascular Endothelial Growth Factor and Leptin Are Associated with Pregnancy Outcome of Normal Women Participating in Intracytoplasmic Sperm Injection Cycles . PHYSIOLOGICAL RESEARCH 54, 263-270. 22-7-2004.
5. Ferrari. Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles. European Journal of Obstetrics & Gynecology andReproductive Biology 124, 70-76. 22-8-2005.
6. Byron Asimakopoulos. Cytokine and hormonal profile in blood serum and follicular fluids during ovarian stimulation with the multidose antagonist or the long agonist protocol. Human Reproduction 21, 3091-3095. 27-9-2006
7. Hamish M Fraser. Regulation of the ovarian follicular vasculature. Reproductive Biology and Endocrinology 4, 1-9. 12-4-2006.
8. D.O.Bates. Regulation of vascular permeability by vascular endothelial growth factors. Vascular Pharmacology 39, 225-237. 2003.
9. Revelli. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reproductive Biology andEndocrinology 7, 1-13. 4-5-2009.
10.Kay elder. In vitro fertilization. 2 ed. 2000. p. 152-86.
11.Howard S.Jacobs. Complications of ovarian stimulation. Baillire's Clinical Obstetrics and Gynaecology 12, 565-579. 4-12-1998.
12.Jack Yu Jen Huang ZR. Preventive Strategies of Ovarian Hyperstimulation Syndrome. J Exp Clin Med 2, 53-62. 5-2-2010.
13.Michelle Davis. Ovarian hyperstimulation syndrome: Aetiology, prevention and management. Reviews in Gynaecological and Perinatal Practice 6, 26-32. 29-3-2006. 14.Louis Chukwuemeka Ajonuma. Is vascular endothelial growth factor (VEGF) the
main mediator in ovarian hyperstimulation syndrome (OHSS)? Medical Hypotheses 70[1174], 1178. 14-11-2007
15.Aboulghara. Elevated levels of interleukin-2, soluble interleukin-2 receptor alpha, interleukin-6, soluble interleukin-6 receptor and vascular endothelial growth factor in serum and ascitic fluid of patients with severe ovarian hyperstimulation syndrome. European Journal of Obstetrics & Gynecology andReproductive Biology 87, 81-85. 18-3-1999.
16.Kaori Koga. Evidence for the Presence of Angiogenin in Human Follicular Fluid and the Up-Regulation of Its Production by Human Chorionic Gonadotropin and Hypoxia. Journal of Clinical Endocrinology & Metabolism 85, 3352-3355. 10-2-2000
17.Domenico Ribatti. The discovery of angiogenic factors: A historical review. General Pharmacology 35, 227-231. 2001.
18.Asimakopoulos. Follicular Fluid Levels of Vascular Endothelial Growth Factor and Leptin Are Associated with Pregnancy Outcome of Normal Women Participating in Intracytoplasmic Sperm Injection Cycles . Physiological Research 54, 263-270. 22-7-2004.
19.Ferrari. Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles. European Journal of Obstetrics & Gynecology andReproductive Biology 124, 70-76. 22-8-2005.
20.Monteleone, paolo giovanni artini. Follicular fluid vegf levels directly correlate with perifollicular blood flow in normoresponder patients undergoing ivf. assist reprod genet 25, 183-186. 5-1-2008.
21.Anasti. Human follicle fluid vascular endothelial growth factor concentrations are correlated with luteinization in spontaneously developing follicles. Human Reproduction 13, 1144-1147. 1-1-1998
22.Ruth Gruemmer. Regulation of soluble vascular endothelial growth factor receptor (sFlt-1/sVEGFR-1) expression and release in endothelial cells by human follicular fluid and granulosa cells. Reproductive Biology andEndocrinology 3, 1-7. 25-10-2005.
23.Guy gutman. Regulation of vascular endothelial growth factor-A and its soluble receptor sFlt-1 by luteinizing hormone in vivo: implication for ovarian follicle angiogenesis. Fertility and Sterility vol 89. 30-3-2007.
24.Yan Zhang. Study on relationship between perifollicular blood flow and in vitro fertilization-embryo transfer. Journal of Nanjing Medical University 22, 57-60. 23-8-2007.
25.Chin der chen. value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. european society of human reproduction and embryology 15[1037], 1042. 5-5-2000.
26.Wen X. Estradiol, progesteron, testosteron profiles in human follicular fluid and cultured granulosa cells from luteinized pre-ovulatory follicles Reproductive biology and endokrinology 2010: 8(117);1-10
27.Pelin O. Follicular fluid concentrations of vascular endothelial growth factor, inhibin A and inhibin B in IVF cycles: are they markers for ovarian response and pregnancy outcome?. European Journal of Obstetrics and Gynaecology and Reproductive Biology 115. 2004 ; 194-99
28.Artini. Vascular endothelial growth factor, interleukin-6 and interleukin-2 in serum and follicular fluid of patients with ovarian hyperstimulation syndrome. European Journal of Obstetrics & Gynecology andReproductive Biology 101, 169-174. 23-10-2001.
29.Moncayo. vegf in serum and follicular fluid of patients undergoing hormonal simulation for ivf. Human Reproduction 13, 3310-3314. 5-4-1998.
30.Yasushi Kawano. Production of vascular endothelial growth factor and angiogenic factor in human follicular fluid. Molecular and Cellular Endocrinology 202, 19-23. 3-3-2003.
31.Linsay J.Macdonald. Prokineticin 1 induces Dickkopf 1 expression and regulates cell proliferation and decidualization in the human endometrium. Molecular Human Reproduction Vol.17, 626-636. 2011.
32.Khalili, Role of oocyte morphology on fertilization and embryo formation in assisted reproductive techniques Middle East Fertility Society Journal Vol. 10, No. 1, 2005:72-7
33.Napoleone Ferrara.VEGF: an update on biological and therapeutic aspects. Pharmaceutical biotechnologyCurrent Opinion in Biotechnology 2000, 11:617–624 34.L.K. Doyle, C.A. Walker, F.X. Donadeu. VEGF modulates the effects of
gonadotropins in granulosa cells.. Division of Developmental Biology, The Roslin Institute and Royal (Dick) School of Veterinary Studies, University of Edinburgh, Roslin BioCentre, Roslin, Midlothian EH25 9PS, Scotland, UK, 31 August 2009L.K. Doyle et al. / Domestic Animal Endocrinology 38 (2010) 127–137.
35.Timothy M. Hazzard. Angiogenesis in ovarian follicular and luteal development. BaillieÁ re's Clinical Obstetrics and Gynaecology. Vol. 14, No. 6, pp. 883-900, 2000.
